Cardia Bioplastics, Biomolecular Engineers Developing Cleaner Polypropylene Carbonate at University Sydney

Cardia Bioplastics, University of Sydney collaborate for PPC polymers

5:20 AM, 11th June 2013
Cardia Bioplastics Research

VICTORIA, AUSTRALIA: Cardia Bioplastics and biomolecular engineers at the University of Sydney are creating cleaner, more cost-effective polypropylene carbonate (PPC) polymers that promise to transform the biodegradable polymer industry. The plastics being developed will have a broad range of usability, at one end of the spectrum being used for fully recyclable shopping bags, at the other, as restorative implants in the human body.

A team led by Fariba Dehghani, Associate Professor, University of Sydney, has commenced a project to design a process for creating purified biodegradable, renewable and CO2 based PPC polymers. “The project’s aim is to minimise reliance on fossil fuels and address the current problems with commercial production of sustainable bio plastics PPC starch not just in Australia but globally,” said Dehghani. The team is developing large scale solvent free technologies that reduce the levels of heavy metal used in PPC.

The outcome of the project will have enormous significance for the environment and human health stated Dehghani. “The clean technologies we develop will make it possible to produce environmentally friendly plastics utilising waste CO2. Converting captured CO2 into products such as chemicals, plastics or other commodities are pivotal in our attempts to reduce the need for volatile organic compounds (VOC). VOCs include a variety of chemicals, some of which can have short or long-term adverse health effects and are also potentially disastrous for our environment,” added Professor Dehghani.

The process being developed by Professor Dehghani’s team could have international reach with its adaptation assisting in reducing carbon emissions in countries where geologic storage of CO2 is impossible. On the health front Professor Dehghani said the synthetic polymer can be used as an alternative for a range of biomedical applications such as musculo-skeletal tissue engineering and drug delivery.

© Cardia Bioplastics News

For the best details of chemical structures, chemical formulas, properties of chemicals, subscribe to worldofchemicals.com - https://www.worldofchemicals.com/

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Solar nanofiltres remove antibiotics from water in lakes, rivers

WASHINGTON DC, US: Using the same devious mechanism that enables some bacteria to shrug off powerful antibiotics, scientists have developed solar-powe ...

Read more
Understanding the behaviour of particles in ionic liquids

CALIFORNIA, US: A new study by researchers at UC Santa Barbara provides clues into the understanding of the behaviour of the charged molecules or part ...

Read more
Arkema expands acrylic acid capacity in Texas, US

COLOMBES, FRANCE: Arkema has brought on stream additional acrylic acid capacity at its Clear Lake, Texas, site, US. A ramp-up period is planned to con ...

Read more
EU, Russia collaborate to control drug precursors

BRUSSELS, BELGIUM: EU and Russia completed signature of a new cooperation agreement on the control of drug precursors, at the EU-Russia Summit in Yeka ...

Read more
Novozymes produces biogas from wastewater

BAGSVAERD, DENMARK: Novozymes and Novo Nordisk use wastewater from the factories in Kalundborg, Denmark for a large scale production of biogas. The ne ...

Read more
BASF opens tert-butylamine plant in Nanjing, China

NANJING, CHINA: BASF announced the opening of its world-scale tert-butylamine (tBA) production plant at the Nanjing Chemical Industry Park in China. T ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X